Vavricka John (CIK 0001829630)

Latest company ownership

Role: Chief Commercial Officer
Shares held
82,508
Last filed at
Feb 2, 2024
Confidence Score
49.7
2025Q4
Confidence Score History
2024Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jan 31, 2025 Feb 4, 2025 Atea Pharmaceuticals, Inc. Chief Commercial Officer Sell 26.3 -2,767 -2.01% $35.2K
Jan 31, 2024 Feb 2, 2024 Atea Pharmaceuticals, Inc. Chief Commercial Officer Sell 28.8 -11,819 -10.20% $45.4K